---
title: "Sino Biopharmaceutical (SBMFF) Receives a Buy from UOB Kay Hian"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293825602.md"
description: "UOB Kay Hian maintained a Buy rating on Sino Biopharmaceutical (SBMFF) with a HK$7.20 price target, following its close at HK$5.15. The stock enjoys a Strong Buy consensus with an average target of HK$8.47, implying 64.46% upside. Morgan Stanley also recently maintained a Buy rating with a HK$7.80 target."
datetime: "2026-07-25T14:55:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293825602.md)
  - [en](https://longbridge.com/en/news/293825602.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293825602.md)
generator: "portal-rs"
---

# Sino Biopharmaceutical (SBMFF) Receives a Buy from UOB Kay Hian

In a report released yesterday, from UOB Kay Hian maintained a Buy rating on Sino Biopharmaceutical, with a price target of HK$7.20. The company’s shares closed last Thursday at HK$5.15.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

Currently, the analyst consensus on Sino Biopharmaceutical is a Strong Buy with an average price target of HK$8.47, implying a 64.46% upside from current levels. In a report released on July 13, Morgan Stanley also maintained a Buy rating on the stock with a HK$7.80 price target.

### Related Stocks

- [01177.HK](https://longbridge.com/en/quote/01177.HK.md)
- [U10.SG](https://longbridge.com/en/quote/U10.SG.md)
- [MS.US](https://longbridge.com/en/quote/MS.US.md)
- [MS-O.US](https://longbridge.com/en/quote/MS-O.US.md)
- [MS-Q.US](https://longbridge.com/en/quote/MS-Q.US.md)
- [MS-E.US](https://longbridge.com/en/quote/MS-E.US.md)
- [MS-I.US](https://longbridge.com/en/quote/MS-I.US.md)
- [MS-L.US](https://longbridge.com/en/quote/MS-L.US.md)
- [MS-P.US](https://longbridge.com/en/quote/MS-P.US.md)
- [MS-A.US](https://longbridge.com/en/quote/MS-A.US.md)
- [MS-F.US](https://longbridge.com/en/quote/MS-F.US.md)
- [MS-K.US](https://longbridge.com/en/quote/MS-K.US.md)

## Related News & Research

- [Sino Biopharma reports Phase I data showing TQC3721 dry powder inhaler boosts COPD lung function in dose-ranging trial](https://longbridge.com/en/news/298202928.md)
- [Sino Biopharm presents ERS 2026 preclinical data for oral STAT6 degrader TQH5528](https://longbridge.com/en/news/298295965.md)
- [Sino Biopharm says FDA clears IND for TQB6426 GPC3 ADC trial in advanced tumors](https://longbridge.com/en/news/297915540.md)
- [Public Relations Portal Introduces Subscription-Based Platform for Recurring Media Placements](https://longbridge.com/en/news/298200631.md)
- [Apalach Current Reaches 2,000 Subscribers as Independent Newsletter Expands Coverage of Florida’s Forgotten Coast](https://longbridge.com/en/news/298468032.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**